Mersana Therapeutics buy Citigroup Inc.
Start price
04.12.23
/
50%
€1.71
Target price
04.12.24
€4.61
Performance (%)
49.88%
Price
26.04.24
€2.73
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ for Mersana Therapeutics has seen massive gains of 49.88%. This prediction currently runs until 04.12.24. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Mersana Therapeutics | -10.507% | -10.507% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Citigroup_Inc_ for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $5.00 price target on the stock, up previously from $1.00.
Ratings data for MRSN provided by MarketBeat